Bank of New York Mellon’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $659K | Sell |
98,028
-2,032
| -2% | -$13.7K | ﹤0.01% | 3341 |
|
|
2025
Q1 | $905K | Sell |
100,060
-1,298
| -1% | -$11.7K | ﹤0.01% | 3111 |
|
|
2024
Q4 | $1.75M | Sell |
101,358
-3,609
| -3% | -$62.4K | ﹤0.01% | 2806 |
|
|
2024
Q3 | $1.68M | Sell |
104,967
-20,469
| -16% | -$327K | ﹤0.01% | 2840 |
|
|
2024
Q2 | $1.79M | Buy |
125,436
+14,838
| +13% | +$211K | ﹤0.01% | 2854 |
|
|
2024
Q1 | $1.57M | Sell |
110,598
-4,462
| -4% | -$63.2K | ﹤0.01% | 2902 |
|
|
2023
Q4 | $1.74M | Buy |
115,060
+48,107
| +72% | +$726K | ﹤0.01% | 2901 |
|
|
2023
Q3 | $1.06M | Buy |
66,953
+566
| +0.9% | +$8.94K | ﹤0.01% | 3116 |
|
|
2023
Q2 | $1.01M | Buy |
66,387
+53,948
| +434% | +$817K | ﹤0.01% | 3186 |
|
|
2023
Q1 | $180K | Hold |
12,439
| – | – | ﹤0.01% | 3947 |
|
|
2022
Q4 | $168K | Buy |
+12,439
| New | +$168K | ﹤0.01% | 4018 |
|
|
2022
Q2 | – | Sell |
-21,933
| Closed | -$206K | – | 4696 |
|
|
2022
Q1 | $206K | Buy |
21,933
+8,276
| +61% | +$77.7K | ﹤0.01% | 4221 |
|
|
2021
Q4 | $234K | Buy |
+13,657
| New | +$234K | ﹤0.01% | 4209 |
|